gastric pentadecapeptide bpc 157 | Frontiers | Stable Gastric Pentadecapeptide

In a study of patients with chronic kidney disease, those with B12 levels 248 pmol/L showed an 83% reduction in the odds of CKD progression compared to enalapril alone when treated with folic acid, while those with lower B12 levels got no benefit from folic acid supplementation

Its made up of 43 amino acids, and is generally taken alongside BPC-157

This research peptide blend is manufactured to exceed 99% purity and tested using HPLC and LC-MS protocols

Sometimes called the wolverine peptide, BPC-157 is marketed as an injury recovery aid and animal studies have been positive

Meaningful cosmetic changes often appear between three and six months of daily use

Self-directed peptide use can also be risky for patients taking multiple medications, patients with liver or kidney concerns, people with bleeding disorders, and anyone who has experienced unusual reactions to injectable products